{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:26:24Z","timestamp":1760523984571,"version":"3.37.3"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/100007607","name":"Aga Khan University","doi-asserted-by":"publisher","award":["DG\/AMB\/01"],"award-info":[{"award-number":["DG\/AMB\/01"]}],"id":[{"id":"10.13039\/100007607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2020,7,24]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Targeting evolutionarily conserved proteins in malignant cells and the adapter proteins\ninvolved in signalling that generates from such proteins may play a cardinal role in the selection of anti-cancer\ndrugs. Drugs targeting these proteins could be of importance in developing anti-cancer drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>We inferred that drugs like loperamide and promethazine that act as antagonists of proteins conserved\nin cancer cells like voltage-gated Calcium channels (Cav), Calmodulin (CaM) and drug efflux (ABCB1)\npump may have the potential to be re-purposed as an anti-cancer agent in Prostate Cancer (PCa).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Growth and cytotoxic assays were performed by selecting loperamide and promethazine to target Cav,\nCaM and drug efflux (ABCB1) pumps to elucidate their effects on androgen-independent PC3 and DU145 PCa\ncell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We show that loperamide and promethazine in doses of 80-100\u03bcg\/ml exert oncocidal effects when\ntested in DU145 and PC3 cell lines. Diphenhydramine, which shares its targets with promethazine, except the\nCaM, failed to exhibit oncocidal effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Anti-cancer effects can be of significance if structural analogues of loperamide and promethazine\nthat specifically target Cav, CaM and ABCB1 drug efflux pumps can be synthesized, or these two drugs could\nbe re-purposed after human trials in PCa.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520620666200409142239","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T19:41:11Z","timestamp":1586461271000},"page":"1017-1027","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Future Oncotargets: Targeting Overexpressed Conserved Protein Targets in Androgen Independent Prostate Cancer Cell Lines"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0626-216X","authenticated-orcid":true,"given":"Abdul M.","family":"Baig","sequence":"first","affiliation":[{"name":"Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohaib","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad M.","family":"Mannan","sequence":"additional","affiliation":[{"name":"Dr. A.Q. Khan Institute of Biotechnology & Genetic Engineering, University of Karachi, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areeba","family":"Khaleeq","sequence":"additional","affiliation":[{"name":"Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizza","family":"Nazim","sequence":"additional","affiliation":[{"name":"Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preet","family":"Katyara","sequence":"additional","affiliation":[{"name":"Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhat","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Aga Khan University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.1038\/s41598-018-26783-w","volume":"8","author":"Liu L.","year":"2018","unstructured":"Liu L.; Chen X.; Hu C.; Zhang D.; Shao Z.; Jin Q.; Yang J.; Xie H.; Liu B.; Hu M.; Ke K.; Synthetic lethality-based identification of targets for anticancer drugs in the human signaling network. Sci Rep May 2018,8(1),8440","journal-title":"Sci Rep May"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","volume":"41","author":"Nieto Gutierrez A.","year":"2018","unstructured":"Nieto Gutierrez A.; McDonald P.H.; GPCRs: Emerging anti-cancer drug targets. Cell Signal 2018,41,65-74","journal-title":"Cell Signal"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"Lappano R.","year":"2011","unstructured":"Lappano R.; Maggiolini M.; G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011,10(1),47-60","journal-title":"Nat Rev Drug Discov"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/CAD.0000000000000432","volume":"28","author":"Mannan Baig A.","year":"2017","unstructured":"Mannan Baig A.; Khan N.A.; Effendi V.; Rana Z.; Ahmad H.R.; Abbas F.; Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer. Anticancer Drugs 2017,28(1),75-87","journal-title":"Anticancer Drugs"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.4103\/0975-7406.100283","volume":"4","author":"Govindarajan R.","year":"2012","unstructured":"Govindarajan R.; Duraiyan J.; Kaliyappan K.; Palanisamy M.; Microarray and its applications. J Pharm Bioallied Sci 2012,4(2),S310-S312","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"Rhodes D.R.","year":"2007","unstructured":"Rhodes D.R.; Kalyana S.; Sundaram V.; The Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007,9,166-180","journal-title":"Neoplasia"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"D938","DOI":"10.1093\/nar\/gkv1030","volume":"44","author":"Tym J.E.","year":"2016","unstructured":"Tym J.E.; Mitsopoulos C.; Coker E.A.; Razaz P.; Schierz A.C.; Antolin A.A.; Al-Lazikani B.; canSAR: an updated cancer research and drug discovery knowledgebase. Nucleic Acids Res 2016,44(D1),D938-D943","journal-title":"Nucleic Acids Res"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"Uhl\u00e9n M.","year":"2015","unstructured":"Uhl\u00e9n M.; Fagerberg L.; Hallstr\u00f6m B.M.; Lindskog C.; Oksvold P.; Mardinoglu A.; Sivertsson \u00c5.; Kampf C.; Sj\u00f6stedt E.; Asplund A.; Olsson I.; Edlund K.; Lundberg E.; Navani S.; Szigyarto C.A.; Odeberg J.; Djureinovic D.; Takanen J.O.; Hober S.; Alm T.; Edqvist P.H.; Berling H.; Tegel H.; Mulder J.; Rockberg J.; Nilsson P.; Schwenk J.M.; Hamsten M.; von Feilitzen K.; Forsberg M.; Persson L.; Johansson F.; Zwahlen M.; von Heijne G.; Nielsen J.; Pont\u00e9n F.; Proteomics. Tissue-based map of the human proteome. Science 2015,347(6220)","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"Kanehisa M.","year":"2016","unstructured":"Kanehisa M.; Sato Y.; Kawashima M.; Furumichi M.; Tanabe M.; KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016,44(D1),D457-D462","journal-title":"Nucleic Acids Res"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1084\/jem.20122292","volume":"210","author":"Leung W-H.","year":"2017","unstructured":"Leung W-H.; Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR\u03b3 activation. J Experim Med 2017,210(12),2675-2692","journal-title":"J Experim Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5217\/ir.2015.13.4.306","volume":"13","author":"Lee K.J.","year":"2015","unstructured":"Lee K.J.; Pharmacologic agents for chronic diarrhea. Intest Res 2015,13(4),306-312","journal-title":"Intest Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0024-3205(83)90506-4","volume":"33","author":"Giagnoni G.","year":"1983","unstructured":"Giagnoni G.; Casiraghi L.; Senini R.; Revel L.; Parolaro D.; Sala M.; Gori E.; Loperamide: evidence of interaction with mu and delta opioid receptors. Life Sci 1983,33(Suppl. 1),315-318","journal-title":"Life Sci"},{"key":"ref=13","author":"Brunton L.L.","year":"2011","unstructured":"Brunton L.L.; Chabner B.A.; Knollmann B.C.;  Goodman  2011","journal-title":"Goodman"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.phrs.2011.11.007","volume":"65","author":"Gong X.W.","year":"2012","unstructured":"Gong X.W.; Xu Y.H.; Chen X.L.; Wang Y.X.; Loperamide, an antidiarrhea drug, has antitumor activity by inducing cell apoptosis. Pharmacol Res 2012,65(3),372-378","journal-title":"Pharmacol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/BF01295711","volume":"38","author":"Awouters F.","year":"1993","unstructured":"Awouters F.; Megens A.; Verlinden M.; Schuurkes J.; Niemegeers C.; Janssen P.A.; Loperamide. Survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sci 1993,38(6),977-995","journal-title":"Dig Dis Sci"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.trecan.2017.01.007","volume":"3","author":"Nussinov R.","year":"2017","unstructured":"Nussinov R.; Wang G.; Tsai C.J.; Jang H.; Lu S.; Banerjee A.; Zhang J.; Gaponenko V.; Calmodulin and PI3K signaling in KRAS cancers. Trends Cancer 2017,3(3),214-224","journal-title":"Trends Cancer"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1292\/jvms.13-0537","volume":"76","author":"Regan R.C.","year":"2014","unstructured":"Regan R.C.; Gogal R.M.; Barber J.P.; Tuckfield R.C.; Howerth E.W.; Lawrence J.A.; Cytotoxic effects of loperamide hydrochloride on canine cancer cells. J Vet Med Sci 2014,76(12),1563-1568","journal-title":"J Vet Med Sci"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1535-7163.MCT-13-0208","volume":"12","author":"Zhu Y.","year":"2013","unstructured":"Zhu Y.; Liu C.; Nadiminty N.; Lou W.; Tummala R.; Evans C.P.; Gao A.C.; Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther 2013,12(9),1829-1836","journal-title":"Mol Cancer Ther"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","volume":"186","author":"Yeh C.T.","year":"2012","unstructured":"Yeh C.T.; Wu A.T.; Chang P.M.; promethazine Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med 2012,186(11),1180-1188","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0277-5379(89)90046-1","volume":"25","author":"Grief F.","year":"1989","unstructured":"Grief F.; Soroff H.S.; Albers K.M.; Taichman L.B.; The effect of Promethazine, a calmodulin antagonist, on the growth of normal and malignant epidermal keratinocytes in culture. Eur J Cancer Clin Oncol 1989,25(1),19-26","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"Kimmelman A.C.","year":"2018","unstructured":"Kimmelman A.C.; Metabolic dependencies in RAS-driven cancers. Clin Cancer Res: Off J Am Assoc Cancer 2018,21(8),1828-1834","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nrc2268","volume":"7","author":"Goymer P.","year":"2007","unstructured":"Goymer P.; Genetics: Conserved by evolution, but altered in cancer. Nat Rev Cancer 2007,7,812-813","journal-title":"Nat Rev Cancer"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/edrv-14-1-40","volume":"14","author":"Lu K.P.","year":"1993","unstructured":"Lu K.P.; Means A.R.; Regulation of the cell cycle by calcium and calmodulin. Endocr Rev 1993,14(1),40-58","journal-title":"Endocr Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nrc2735","volume":"9","author":"Mancini M.","year":"2009","unstructured":"Mancini M.; Toker A.; NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009,9(11),810-820","journal-title":"Nat Rev Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3892\/or.10.6.2023","volume":"10","author":"Abdul M.","year":"2003","unstructured":"Abdul M.; Hoosein N.; Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen. Oncol Rep 2003,10(6),2023-2026","journal-title":"Oncol Rep"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T11:17:03Z","timestamp":1603451823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180815\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,7,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520620666200409142239","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}